About Sekhmet Pharmaventures
Sekhmet Pharmaventures is a Healthcare company based in Mumbai (India) founded in 2020. Stakes in fast-growing Indian pharma companies are acquired and developed. It operates on a B2B2C and Reseller / Distribution model. The company has 12 employees. Its chief executive, as recorded, is Anil Khubchandani. Its Indian entity Sekhmet Pharmaventures Private Limited reported revenue of ₹1,064 Cr. Sekhmet Pharmaventures offers products and services including Active Pharmaceutical Ingredients (API), Finished Dosage Formulations, and CMO & CDMO Services. Its focus areas include Pharmaceuticals and Active Pharmaceutical Ingredients.
Company details
Sekhmet Pharmaventures is involved in the acquisition and operation of active pharmaceutical ingredient (API) businesses. Based in Mumbai, India, the company is focused on building a leading pharmaceutical platform by leveraging select assets, introducing synergies, and accelerating research and development. Operations span intermediates, APIs, finished dosage formulations, and contract manufacturing and development (CMO CDMO) services. The company pursues both inorganic and organic growth strategies to strengthen its presence in the pharmaceutical sector.
- Headquarters Mumbai, India
- Employees 12
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website sekhmetpharma.com
- Social LinkedIn X
- Legal Name Sekhmet Pharmaventures Pvt Ltd
- Date of Incorporation 23 Jun, 2020
- Jurisdiction Mumbai, Maharashtra, India
- Annual Revenue₹1,064 Cr
FY 2025 · +1% YoY
- Net Loss-₹234 Cr
FY 2025 · -22% margin
- EBITDA-₹16.71 Cr
FY 2025 · -2% margin
- Investors
- Employee Count12
Associated legal entities of Sekhmet Pharmaventures
Sekhmet Pharmaventures operates through Sekhmet Pharmaventures Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Sekhmet Pharmaventures Private Limited CIN U74999MH2020PTC340954 | Active | 23 Jun 2020 | Mumbai, Maharashtra | ₹1,064 Cr | 12 | 9 | View details |
Products & Services of Sekhmet Pharmaventures
Sekhmet Pharmaventures offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients (API), Finished Dosage Formulations, and CMO & CDMO Services.
Active pharmaceutical ingredients are developed for medicinal formulations.
Finished dosage formulations are produced for direct use.
Contract manufacturing and development services are provided efficiently.
Funding Insights of Sekhmet Pharmaventures
- Total Rounds 1
- Investors Count 1
All 1 funding rounds of Sekhmet Pharmaventures with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2020 | Private Equity Round | – | – |
1 investors in total: 1 institutional.
Investors in Sekhmet Pharmaventures
Sekhmet Pharmaventures has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CX Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments in India are managed by CX Partners. | cxpartners.in | Delhi, India |
Investor details for Sekhmet Pharmaventures
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Sekhmet Pharmaventures Private Limited (Sekhmet Pharmaventures)
Sekhmet Pharmaventures Private Limited is the primary company behind Sekhmet Pharmaventures. The board of Sekhmet Pharmaventures Private Limited currently have 6 directors; the longest-serving is Nikhil Kumar Srivastava, appointed in 2020. 12 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Nikhil Kumar Srivastava DIN 07308617 | Director | 03 Oct 2020 | 6 yrs 1 mo | Sekhmet Pharmaventures Private Limited |
| Anchit Gupta DIN 06436849 | Director | 04 Dec 2020 | 5 yrs 11 mo | Sekhmet Pharmaventures Private Limited |
| Vivek Chhachhi DIN 00496620 | Director | 04 Dec 2020 | 5 yrs 11 mo | Sekhmet Pharmaventures Private Limited |
| Aswin Vikram DIN 08895013 | Director | 28 Oct 2022 | 4 yrs | Sekhmet Pharmaventures Private Limited |
| Santosh Kumar Mahil DIN 07584287 | Managing Director | 03 Jun 2025 | 1 yr 5 mo | Sekhmet Pharmaventures Private Limited |
| Mukesh Kumar Sitaram Agarwal DIN 11528447 | Whole-time director | 18 Mar 2026 | 7 mo | Sekhmet Pharmaventures Private Limited |
People of Sekhmet Pharmaventures
1 people are tracked at Sekhmet Pharmaventures (1 in leadership); the tracked headcount is 12.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership |
Complete people profiles for Sekhmet Pharmaventures
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Sekhmet Pharmaventures
Figures of Sekhmet Pharmaventures Private Limited, the primary company behind Sekhmet Pharmaventures, for FY 2025. Revenue was ₹1,064 Cr (+1% year on year). Net loss was -₹234 Cr (-22% margin). EBITDA was -₹16.71 Cr (-2% margin). Revenue has grown at a compounded annual rate of +78% over three years.
- ₹1,064 CrRevenue · FY 2025 · +1% YoY
- -₹234 CrNet loss · -22% margin
- -₹16.71 CrEBITDA · -2% margin
- ₹2,063 CrPaid-up capital
- 12Employees (provident fund records)
- +78%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Sekhmet Pharmaventures Private Limited are on its company page.
Detailed financial statements for Sekhmet Pharmaventures
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Sekhmet Pharmaventures
2 dated milestones of Sekhmet Pharmaventures, from founding to its latest funding, stage changes and deals.
- Founded Sekhmet Pharmaventures is founded.
- Funding First funding round.
Web traffic of Sekhmet Pharmaventures
The website of Sekhmet Pharmaventures (sekhmetpharma.com) receives about 2K visits a month.
- Monthly visits2K
▲ 13.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Sekhmet Pharmaventures
Complete news archive for Sekhmet Pharmaventures
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sekhmet Pharmaventures
Sekhmet Pharmaventures was founded in 2020.
Sekhmet Pharmaventures is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Anil Khubchandani is the CEO of Sekhmet Pharmaventures, as recorded in our data.
Sekhmet Pharmaventures has 12 employees.
The primary company behind Sekhmet Pharmaventures, Sekhmet Pharmaventures Private Limited, reported revenue of ₹1,064 Cr for FY 2025, up 1% year on year.
Sekhmet Pharmaventures is involved in the acquisition and operation of active pharmaceutical ingredient (API) businesses. Based in Mumbai, India, the company is focused on building a leading pharmaceutical platform by leveraging select assets, introducing synergies, and accelerating research and development. Operations span intermediates, APIs, finished dosage formulations, and contract manufacturing and development (CMO CDMO) services. The company pursues both inorganic and organic growth strategies to strengthen its presence in the pharmaceutical sector.
Sekhmet Pharmaventures offers Active Pharmaceutical Ingredients (API), Finished Dosage Formulations, and CMO & CDMO Services.
Sekhmet Pharmaventures has 1 investor. Key investors include CX Partners.
Sekhmet Pharmaventures operates through Sekhmet Pharmaventures Private Limited.
The legal entities of Sekhmet Pharmaventures currently have 7 directors, including Aswin Vikram, Anchit Gupta, Vivek Chhachhi and others.